photo
Speaker

Melanie Matheu

CEO, PRELLIS BIOLOGICS
Hayward, California, United States
Dr Matheu is a research scientist turned entrepreneur with cross-disciplinary experience in Immunology, Chemistry, Biophysics, Molecular Biology, and Protein Engineering. With a specialty (>15 years) in 2-photon imaging of immune responses.

She has filed 12 patents, worked on 2 immunotherapeutics, covered biotechnology companies for investors for over 20 years, and served as the youngest member on the SAB of a companion animal medicine company. Her first patent work was at the age of 19 in the field of synthetic organic chemistry.

Two compounds vetted in her PhD research entered and completed positive FDA trials with positive Phase IIb results, and one FDA approved and acquired by Celgene. In her academic career she was awarded over $1M in academic grant funding for independent projects and research.
Speaking In
[Available On-Demand]
Prellis Biologics is a human tissue engineering company that has replicated the human immune system…